| Novelix Pharmaceuticals Limited, formerly TRIMURT HI LIMITED, will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, along with a limited review report from the auditors. The company, with Scrip Code 586565 and Scrip Id NOVELIX, has closed the trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the board meeting’s conclusion, in accordance with SEBI regulations. |